Tags

Type your tag names separated by a space and hit enter

[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Virologie (Montrouge). 2020 Jun 01; 24(3):135-141.V

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Nisole S
Institut de recherche en infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, Montpellier, France.
Saulnier A
À titre personnel.
Gatignol A
Laboratoire des interactions Virus-Cellule, Institut Lady Davis de recherches médicales ; Département de médecine, Département de microbiologie et immunologie, Université McGill, Montréal, Québec, Canada.

MeSH

Anti-Inflammatory AgentsAntiviral AgentsBetacoronavirusCOVID-19Coronavirus InfectionsCytokinesHumansPandemicsPneumonia, ViralSARS-CoV-2COVID-19 Drug Treatment

Pub Type(s)

Editorial
Review

Language

fre

PubMed ID

32648548

Citation

Nisole, Sébastien, et al. "[Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Should We Target the Virus, the Cell or the Disease?]." Virologie (Montrouge, France), vol. 24, no. 3, 2020, pp. 135-141.
Nisole S, Saulnier A, Gatignol A. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?]. Virologie (Montrouge). 2020;24(3):135-141.
Nisole, S., Saulnier, A., & Gatignol, A. (2020). [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?]. Virologie (Montrouge, France), 24(3), 135-141. https://doi.org/10.1684/vir.2020.0843
Nisole S, Saulnier A, Gatignol A. [Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Should We Target the Virus, the Cell or the Disease?]. Virologie (Montrouge). 2020 Jun 1;24(3):135-141. PubMed PMID: 32648548.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?]. AU - Nisole,Sébastien, AU - Saulnier,Aure, AU - Gatignol,Anne, PY - 2020/7/11/entrez PY - 2020/7/11/pubmed PY - 2020/7/22/medline SP - 135 EP - 141 JF - Virologie (Montrouge, France) JO - Virologie (Montrouge) VL - 24 IS - 3 SN - 1267-8694 UR - https://www.unboundmedicine.com/medline/citation/32648548/[Severe_acute_respiratory_syndrome_coronavirus_2��_SARS_CoV_2_:_Should_we_target_the_virus_the_cell_or_the_disease]_ DB - PRIME DP - Unbound Medicine ER -